Group items tagged

In humans, a deficiency of growth hormone is caused when the pituitary gland does not include adequate concentration of human growth hormone. This deficiency is treated by injecting human growth hormone with a subcutaneous injection. Various genetic disorders such as Prader-Willi syndrome and Turner syndrome can also cause growth hormone deficiency, resulting in delayed puberty and shorter height than averages.

Achondroplasia is a genetic disorder of bone development that prevents bone changes in cartilage (especially in the long bones of the hands and feet). It is characterized by the limited range of motion at the elbows, dwarfism, small fingers, large head size, and normal intelligence. Achondroplasia is caused by a change in the FGFR3 (fibroblast growth factor receptor 3) gene and occurs as a result of a spontaneous genetic mutation in around 80% of patients, with the remaining 20% inherited from parents. Individuals with achondroplasia have short stature. The average height in men is 4 feet 4 inches and in women is 4 feet 1 inch. Achondroplasia treatment may include medications with growth hormone and surgery to correct an abnormal curvature of the spine (or bone problems), as to reduce the pressure inside the brain in cases of hydrocephaly. Achondroplasia is known to affect 1 in 15,000 to 40,000 newborns. The average adult height of those affected ranges from 4 feet to 4.4 feet. In the United States, around 10,000 individuals are living with achondroplasia, of equal frequency in men and women and across all racial and ethnic groups, making it the most common skeletal dysplasia. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/growth-hormone-therapy-and-surgery-are.html

Hair loss can occur due to hormonal imbalance, pregnancy, thyroid, emotional stress or other reasons, we provide hair loss treatment in Dubai and many other

We offer pregnancy tests at our Clinic by a choice of blood test and urine test. All pregnancy tests measure the amount of human chorionic gonadotrophin (hCG), the pregnancy hormone, in your body.

What is Depression? Every individual experiences feelings of worthlessness, sadness, and negativity. It is when these feelings spiral out of control and consume the individual to an extent that his/her normal life is disrupted, that depression arises. Depression is a serious medical condition and can significantly weaken the individual both physically and mentally. What are the causes and risk factors of depression? In medical terms, depression is due to a decreased amount of certain chemicals in the brain. Depression has a genetic basis, i.e. depression may run in family. It can also be triggered by an event such as the loss of a loved one, losing a job, etc. There are some hormonal problems like decreased thyroid levels that can also lead to depression. Depression can also follow after the diagnosis of a serious illness and leads to impaired treatment of the disease. It is accompanied by the feeling of not getting well and hence ignoring the medication and the other activities that have been advised by the doctor. Risk factors Traumatic past, abuse, neglect Loss of a loved one Serious medical conditions like Parkinson's disease, etc. Also Read: How to Prevent Depression in Elderly What are the symptoms of depression? Persisting feeling of sadness, anxiety Low self-esteem Feeling worthless Pessimistic mindset Decreased appetite Difficulty in sleeping Oversleeping Inability to concentrate Talking, walking slowly Constantly feeling tired Loss of interest in activities that were previously enjoyable Decreased sexual desire Weight loss Headache Abdominal cramps Having ideas about death, contemplating suicide What are the investigations for depression? As such there are no investigations for depression. If the symptoms listed above continue for more than two weeks, the person is diagnosed with depression. Investigations advised by the doctor can be - Thyroid function tests Cortisol levels in the blood What is the treatment of depression? The treatment is both

Apollo hospitals Mumbai offers breast cancer treatment which includes surgical procedures, radiation therapy, chemotherapy and hormonal therapy.

High potency active pharmaceutical ingredients are molecules widely used in the production of hormonal drugs which are used for the treatment of breast cancer. It is also used in the central nervous system drugs, cardiovascular drugs, and musculoskeletal drugs. Moreover, recently they have been also gaining demand in the gynecology & cosmetics industry. These drugs are segmented into innovative and generic. The growing prevalence of cancer is predominantly fueling the growth of the high potency active pharmaceutical ingredients market. The increasing number of the pharmaceutical industry coupled with the growing investment in the research and development activities conducted by the pharmaceutical industry is again contributing to the market growth. Moreover, increasing use of high potency active pharmaceutical ingredients as antibody-drug conjugates as it is one of the most important and effective treatments for cancer is also projected to augment the market growth. It is also used to treat glaucoma which is further anticipated to foster the growth of the high potency active pharmaceutical ingredients market. From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of chronic disease in the region. Read more @ https://sachinbhombe.blogspot.com/2021/03/high-potency-active-pharmaceutical.html

Pulmonary Arterial Hypertension (PAH) is a disease that affects the vasculature of the heart, specifically the arteries that transport blood from the heart to the lungs. Common symptoms include heart palpitations or an irregular rhythm, chest pain, coughing, wheezing, shortness of breath, chest discomfort when breathing, and sometimes even heart failure. The cause of pulmonary hypertension is not known, but research has indicated that genetic and hormonal factors may play a role in its development. The growing prevalence of Pulmonary Arterial Hypertension (PAH) is driving the growth of the Pulmonary Arterial Hypertension (PAH) Market. According to the European Respiratory Society, PAH is a rare disease, with an estimated prevalence ranging from 10 to 52 cases per million. The growing geriatric population is again increasing the prevalence of such disease which is also projected to foster the growth of the Pulmonary Arterial Hypertension (PAH) market. According to the United nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. North America is projected to gain significant growth over the forecast period and this is attributed to the growing adoption of advanced treatment for treating pulmonary arterial hypertension. Moreover, increasing spending by the government on the healthcare sector is again augmenting the regional market growth. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028. Reads more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-global-healthcare-spending.html

Hyperphosphatemia is a condition caused by high levels of phosphorous or phosphate in the blood. This condition may be due to decreased emission of phosphate, excessive intake of phosphate, and the shift of phosphate from intracellular to extracellular. High phosphate levels in the blood can be avoided with the use of phosphate binders or by dietary restrictions. Phosphate is a chemical found in the human body and contains a mineral called phosphorous. It is important for the development of bones and teeth and also converts food into energy for the body. Some other possible causes of hyperphosphatemia include low levels of parathyroid hormone, high levels of vitamin D, uncontrolled diabetes, and diabetic ketoacidosis. The factors such as the growing geriatric population and increasing prevalence of chronic diseases worldwide are expected to drive the hyperphosphatemia drugs market in the coming future. Hyperphosphatemia is a primary cause of mortality and morbidity in people with chronic kidney disease. According to the Centers for Disease Control and Prevention (CDC), around 37 million adults in the United States are likely to have chronic kidney disease and most are undiagnosed. It is rare in the general population, but in people with chronic kidney disease, the rate of hyperphosphatemia is at least 70%. Since the increased risk of death from heart disease and hyperphosphatemia are associated with each other. This, in turn, increases the risk of heart disease in people suffering from hyperphosphatemia. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-prevalence-of-chronic-kidney.html

Peptic ulcer drugs are medicines that are used to help fight and treat the symptoms of ulcers in stomach. These drugs, when taken regularly, can stop the production of certain hormones, such as pancreatic enzymes which are responsible for the digestion of foods. When the stomach produces too many enzymes, this can result in a painful ulcer. The first introduction of Peptic Ulcer Drugs was in the 1930s and it is still an important part of medical treatment today. Histological research on ulcers in patients who had undergone ulcer surgery showed that ulcers developed because of a reduced digestive system and inadequate absorption of nutrients in the intestines. The first Peptic Ulcer Drugs, introduced in the United States were drugs which helped to improve the absorption and metabolism of proteins and carbohydrates in the bloodstream. Other Peptic Ulcer Drugs include drugs that reduce the inflammation of the lining of the stomach and lower the levels of certain enzymes which can cause ulcer growth. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/the-rise-in-prevalence-of-peptic-ulcer.html

Various forms of sugar (candy, soda, canned food) might be enhancing the hunger-suppressing hormones, especially in young adults. #fructose #Glucose #sucrose #hungersuppressinghormones